Ivan Bergstein, Chief Executive Officer at STEMLINE THERAPEUTICS INC (STML), sold 48,366 shares at $17.61 ($842K) on 2018-02-26, disclosed to the SEC on 2018-02-28.
Seasonal sale ($842k) by Chief Executive Officer — this insider has traded STML in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.61 | 10,776 | $190K | 22.5% |
| 2 | $17.61 | 10,776 | $190K | 22.5% |
| 3 | $17.26 | 13,407 | $231K | 27.5% |
| 4 | $17.26 | 13,407 | $231K | 27.5% |
| Total | $17.42 avg | 48,366 | $842K | 100% |
| Filing → |
| STML | SELL | 2020-02-28 | $316K | — | Filing → |
| STML | SELL | 2020-01-03 | $987K | — | Filing → |
| STML | SELL | 2019-08-16 | $1.0M | — | Filing → |